コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 s mechanistically distinct from drug-induced erythema multiforme.
2 e designated herpes simplex virus associated erythema multiforme.
3 pothyroidism; grade 3 iridocyclitis, grade 1 erythema multiforme, and grade 3 erythema; and grade 2 i
4 lupus erythematous tumidus, Wells syndrome, erythema multiforme, cutaneous mastocytosis, cryopyrin-a
11 .08), lichenoid dermatitis (IC(025) = 3.69), erythema multiforme (IC(025) = 1.03), toxic epidermal ne
12 Lesional herpes simplex virus associated erythema multiforme keratinocytes also stained with anti
13 dicated that herpes simplex virus associated erythema multiforme lesional skin from 16 of 21 (76%) DN
14 on-eczematous contact dermatitis include the erythema multiforme-like, the purpuric, the lichenoid, a
15 immunobullous, psoriasiform, granulomatous, erythema multiforme or Stevens Johnson Syndrome, drug ra
16 eumonitis, localized myositis, folliculitis, erythema multiforme, or ophthalmological manifestations.
17 ndicate that herpes simplex virus associated erythema multiforme pathology includes a delayed-type hy
18 ase positive herpes simplex virus associated erythema multiforme patients was also positive for inter
20 of 26 (81%) herpes simplex virus associated erythema multiforme patients was positive for herpes sim
21 and lesional keratinocytes from drug-induced erythema multiforme patients were negative for transform
22 lex virus or herpes simplex virus associated erythema multiforme patients, and lesional keratinocytes
23 , was seen in seven of 11 (64%) drug-induced erythema multiforme patients, but not in herpes simplex
25 n in other closely related syndromes such as erythema multiforme, Stevens-Johnson syndrome, and toxic
26 ion, with a median of approximately 1 month (erythema multiforme, Stevens-Johnson syndrome, and toxic